Top news on NAFLD, NASH: cases in children, quality of life concerns, treatment updates

Healio handpicked its top stories on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, which highlight risks for children with NAFLD, how fatigue relates to quality of life, treatment with resmetirom and more.Prenatal exposure to endocrine-disrupting chemicals may be a cause of increased incidence of nonalcoholic fatty liver disease in children, according to a study published in JAMA Network Open.Vishal Midya, PhD, MStat, a postdoctoral fellow in the department of environmental medicine and public health at Icahn School of Medicine at Mount Sinai, and colleagues reported thatRead More

Categories: News

Related Articles

Prenatal exposure to endocrine-disrupting chemicals tied to ‘NAFLD epidemic’ in children

Prenatal exposure to endocrine-disrupting chemicals may be a cause of increased incidence of nonalcoholic fatty liver disease in children, according to a study published in…

Fatigue linked to worse clinical prognosis, quality of life in patients with NAFLD

LONDON — Lower fatigue scores at baseline correlated with adverse clinical events among patients with advanced nonalcoholic steatohepatitis, according to research presented at the International…

HIV an independent risk factor for nonalcoholic steatohepatitis

A study of more than 1,300 women demonstrated that HIV is an independent risk factor for nonalcoholic steatohepatitis with significant nonalcoholic fatty liver disease activity…

Resmetirom ‘has potential to be first medication approved’ for patients with NASH

LONDON — Resmetirom was safe and well tolerated at 100 mg and 80 mg doses in patients with nonalcoholic steatohepatitis, according to late-breaking research presented…

2018 FGS Annual Meeting Registration Is Now Open!

Registration for the 2018 FGS Annual Meeting is now open! We will be returning to the Hyatt Regency Grand Cypress this September 14-16, 2018. Short…

Justin Bouck May 22, 2018